Dozens of governments are looking to attack, from Latin America to the Middle East. Australia is currently offering vaccines after shifting from its competitors. Turkey, the United Kingdom and Chile are offering Pfizer-BioNTech vaccines to those who have taken other shots.
Demand was so high in Argentina that the country rewrote a new vaccine purchasing law so that it could reach a contract with Pfizer.
“Everyone wants to get the best vaccine,” said epidemiologist and former Brazilian Ministry of Health official Wanderson de Oliveira, who increased the use of Pfizer-BioNTech this year. Shift from Chinese jabs..
“Pfizer’s Covid-19 vaccine shows superior results compared to other vaccines,” he said.
Each country purchased 3.5 billion doses of Pfizer-BioNTech vaccine. This is about a billion times more than the vaccine I bought.
According to the Duke Global Health Innovation Center, PLC is the second largest supplier in the world.
Pfizer said it has shipped more than 1.6 billion doses to more than 130 countries so far.
According to government officials and industry analysts, what is driving the popularity is the high effectiveness of the vaccine. Highly contagious delta mutant,none Concerns about blood clotting Damaged the uptake of AstraZeneca
Also, according to research and government officials, the protection provided by the Pfizer-BioNTech vaccine has not diminished over time as much as the Chinese vaccine, and its supply is not restricted. Similar to Russian Sputnik V shooting..
According to officials and analysts, there is still a lot of demand for other vaccines. Analysts say that especially many low- and middle-income countries are likely to rely on their rivals. Pfizer cannot be produced worldwide, and competitors can store it more easily and it can be cheaper.
Due to the growing popularity of vaccines, Pfizer has raised prices in some countries. Israeli health ministry officials told public broadcaster Kan in December that the government had not officially confirmed the numbers, but paid $ 62 each time. This is a much higher price than most countries pay. Pfizer has raised the European Union price from $ 18 to $ 23 each time.
According to Brazilian media reports, Pfizer offered a dose of $ 12 each under a contract with Brazil in May. According to a copy of the deal reviewed by The Wall Street Journal, this was higher than the $ 10 per offer from the March deal.
The Brazilian and Israeli governments refused to comment on prices. Pfizer said vaccines are offered in gradual pricing, with middle-income countries paying about half the price paid by wealthy countries and low-income countries paying.
According to Bernstein Research analyst Ronny Gal, the popularity of Pfizer-BioNTech Shots will allow New York pharmaceutical companies to gain a greater share of the global vaccine market. Pfizer owns PrevnarThe world’s best-selling pneumonia vaccine, last year’s sales were $ 5.9 billion.
The World Health Organization estimates that the global vaccine market, excluding the Covid-19 vaccine, is worth $ 33 billion annually worldwide. Gal estimates that Covid-19 shots and boosters could add $ 3 to $ 15 billion annually to the market size after 2023, depending on booster recommendations.
“It looks like no other company could threaten our advantage in the Covid-19 market,” Gal said. As mRNA technology is validated and regulators are familiar with it, Pfizer should face an easier time to get government approval for future shots the company develops, Gal added.
According to analysts, Pfizer produces similar mRNA-based vaccines because of its greater commercial and manufacturing capacity, but it is not widely used.Also, the partnership between Pfizer and Israel Real-world validity data obtained It helps the country make vaccination decisions.
In some countries, the use of Moderna shots by certain groups is restricted due to the following risks: Rare inflammatory heart disease, This was also seen A few young people Pfizer-People who have taken BioNTech shots.
Moderna predicts that it will generate a billion doses this year, compared to Pfizer’s 3 billion forecast. Pfizer and BioNTech said they could produce 4 billion doses next year.
After a limited start, Pfizer and BioNTech began building production early in the pandemic before they knew if the vaccine would work. Pfizer is expanding its manufacturing footprint, bringing contract manufacturers to Brazil, South Africa, Italy and elsewhere, and partner BioNTech has assembled another contractor suite.
French pharmaceutical company
soon Abandonment of Covid-19 vaccine developmentDespite promising research results, the mRNACovid-19 vaccine market is overcrowded.
Pfizer’s preference seeks supply contracts with Western companies, Russia, or China, where many countries used traditional techniques to develop shots rather than then-unproven gene-based mRNA technology. It is a shift from last year that I chose to do.
Wool Shahin, CEO of BioNTech, said:
Share your thoughts
How will success in the Covid-19 vaccine race change Pfizer’s future? Join the conversation below.
BioNTech is also poised to benefit from the success of the vaccine and has emerged as a global pharmaceutical company in its own right. Analysts said the revenue from Covid-19’s supply agreement would help fund the company’s experimental and vaccine pipeline.
Australia began offering Pfizer doses after first focusing on shots from AstraZeneca
University of Queensland. The government abandoned the CSL-Queensland candidate in December because the recipients of early clinical trials were mistakenly HIV positive. In April, Australia advised older people not to take shots of AstraZeneca because of the rare but high risk of blood clots in women.
With the July Covid-19 surge, Australia revisited AstraZeneca’s guidelines and recommended them to all adults at the time of the outbreak, but the number of people who followed the advice when the country pushed Pfizer’s shots. Unknown.
In search of additional supplies, Australia received 4 million Pfizer shots from the United Kingdom, 1 million from Poland and 500,000 from Singapore.
Turkey’s first bet on a Chinese vaccine was rewarded early when Pfizer-BioNTech doses were limited. However, the country has recently moved to Pfizer-BioNTech Jab. This includes two doses to re-vaccine people who have taken Sinovac shots in China.
Turkey’s Ministry of Health said it is offering Pfizer shots to encourage trips to countries that have not approved China’s vaccine, and Turkish officials said Dr. Sahin of Turkey’s BioNTech, who later moved to Germany. He said supply increased after the meeting with.
A former member of the Turkish Ministry of Health’s Coronavirus Commission said that scientific data collected by the government regarding the relative efficacy of the vaccine could also influence the decision to re-vaccine those who first received the Sinovac shot. He said it was highly sexual.
Abu Dhabi, the capital of the United Arab Emirates, has recently begun to restrict access to public places for those who received the China National Pharmaceutical vaccine more than six months ago, unless they obtained a booster. These restrictions do not apply to anyone taking a Pfizer-BioNTech shot.
UK currently recommends Pfizer-BioNTech shots Country booster campaign Instead of UK-based AstraZeneca. AstraZeneca vaccination was widely used in the early stages of national vaccination deployment, but is now recommended as a booster only if you are allergic to Pfizer vaccination.
Argentina initially rejected the Pfizer-BioNTech vaccine, partly because Pfizer insisted on protecting the country from liability for injuries caused by shots. A national vaccine law passed in October to control the purchase of shots could put Pfizer in a proceeding if a person was severely ill by a company vaccine.
However, the government has changed course due to the Argentinean’s “attachment to Pfizer” as the delivery of the Sputnik V vaccine was delayed in the wave of infection and death, said Health Minister Carla Vizzotti.
In July, Argentina issued a decree to remove the wording of negligence from the Vaccine Act in response to Pfizer and established a fund to compensate those affected by the vaccine. According to the deal, in August the country signed a deal of more than 20 million shots for $ 12 each, which is more expensive than the deal between Sputnik and AstraZeneca.
“This is very important, as it is the vaccine that has been shown to be most effective with Moderna,” said Congressman Graciela Ocaña.
—Rory Jones, Jared Malsin, Silvina Frydlewsky, Luciana Magalhaes contributed to this article.
Copyright © 2021 DowJones & Company, Inc. all rights reserved. 87990cbe856818d5eddac44c7b1cdeb8
Pfizer-BioNTech Covid-19 Vaccine is the World’s Most Favorite Shot
Source link Pfizer-BioNTech Covid-19 Vaccine is the World’s Most Favorite Shot